D. Richardson

Molecular Biology · Pharmacological Reviews · 2005–2021

A researcher in the Science corpus: 4 papers; trusts 9 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom D. Richardson trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Vladimir Torchilin
  2. Y. Barenholz
  3. R. Müller
  4. K. Mäder
  5. T. Ganz

Papers from D. Richardson's perspective

Ordered by how strongly the researchers D. Richardson trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Recent advances with liposomes as pharmaceutical carriers (Nature reviews. Drug discovery)
  2. Targeted pharmaceutical nanocarriers for cancer therapy and imaging (AAPS Journal)
  3. Active targeting schemes for nanoparticle systems in cancer therapeutics. (Advanced Drug Delivery Reviews)
  4. Micellar Nanocarriers: Pharmaceutical Perspectives (Pharmaceutical Research)
  5. Targeting nanoparticles to cancer. (Pharmacological Research)
  6. Nanoparticle therapeutics: an emerging treatment modality for cancer (Nature reviews. Drug discovery)
  7. Structure and design of polymeric surfactant-based drug delivery systems. (Journal of Controlled Release)
  8. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. (Cancer Research)
  9. Cancer nanotechnology: opportunities and challenges (Nature Reviews. Cancer)
  10. Openings between defective endothelial cells explain tumor vessel leakiness. (American Journal of Pathology)

Their papers